Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP331889.RAOKYDy6hdBDYltNJ8L_99BZmCqcDIDGe91IUUtjitBik130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP331889.RAOKYDy6hdBDYltNJ8L_99BZmCqcDIDGe91IUUtjitBik130_assertion type Assertion NP331889.RAOKYDy6hdBDYltNJ8L_99BZmCqcDIDGe91IUUtjitBik130_head.
- NP331889.RAOKYDy6hdBDYltNJ8L_99BZmCqcDIDGe91IUUtjitBik130_assertion description "[Dose-dependent reduction in EGF-stimulated A549 motility was observed with the PD98059 MEK1 inhibitor and the batimastat (BB-94) inhibitor of MMP activity, but not with the SB203580 inhibitor of p38 kinase.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331889.RAOKYDy6hdBDYltNJ8L_99BZmCqcDIDGe91IUUtjitBik130_provenance.
- NP331889.RAOKYDy6hdBDYltNJ8L_99BZmCqcDIDGe91IUUtjitBik130_assertion evidence source_evidence_literature NP331889.RAOKYDy6hdBDYltNJ8L_99BZmCqcDIDGe91IUUtjitBik130_provenance.
- NP331889.RAOKYDy6hdBDYltNJ8L_99BZmCqcDIDGe91IUUtjitBik130_assertion SIO_000772 11585739 NP331889.RAOKYDy6hdBDYltNJ8L_99BZmCqcDIDGe91IUUtjitBik130_provenance.
- NP331889.RAOKYDy6hdBDYltNJ8L_99BZmCqcDIDGe91IUUtjitBik130_assertion wasDerivedFrom befree-2016 NP331889.RAOKYDy6hdBDYltNJ8L_99BZmCqcDIDGe91IUUtjitBik130_provenance.
- NP331889.RAOKYDy6hdBDYltNJ8L_99BZmCqcDIDGe91IUUtjitBik130_assertion wasGeneratedBy ECO_0000203 NP331889.RAOKYDy6hdBDYltNJ8L_99BZmCqcDIDGe91IUUtjitBik130_provenance.